Medication-misrecording risk in AI scribes — safety QA + attestation

Medication-misrecording risk in AI scribes — safety QA + attestation targets a $15.0B = 100,000 healthcare organizations (hospitals, health systems, large clinic chains) x $150K ACV (enterprise safety & QA software). total addressable market with medium saturation and a year-over-year growth rate of 18% annually for clinical AI documentation & QA solutions.

Key trends driving demand: Ambient-AI adoption -- more clinics deploy ambient scribe systems, creating demand for safety/QA adjuncts.; Regulatory scrutiny -- payers and regulators push for auditable, accurate clinical documentation to reduce adverse events and billing risk.; EHR integration standards -- FHIR/SMART improvements lower friction for third-party verification modules and attestation workflows.; Clinical liability focus -- malpractice and patient-safety initiatives prioritize tools that reduce medication errors and build audit trails..